Home Blog Page 958

AI Irony: Executives champion AI but underinvest in the skills and oversight needed to realise returns

LONDON, March 23, 2026 /PRNewswire/ — Business leaders overwhelmingly believe in AI’s potential, but most organisations fail to invest in the workforce and governance needed to make it pay off, according to new research from Economist Impact and supported by Kyocera Document Solutions, a leading provider of total document solutions.

Based on a survey of 639 executives across London, New York, Tokyo, Sydney, and Singapore, the report highlights a disconnect between AI ambition and organisational readiness.

While 88% of executives view AI as a source of competitive advantage, only 38% report sufficient budgets for AI training. As a result, just 4% of executives say their organisations have achieved repeatable, scalable business value from AI.

Despite near-universal claims that companies are building AI skills (99%), most companies rely on informal approaches such as mentorship (54%) and self-directed learning (52%). External partnerships (21%) and structured internal programmes (16%) remain limited, restricting capability-building across the workforce. Where training exists, almost half of executives say it reaches less than 10% of their employees.

Governance presents a similar gap. Although organisations widely acknowledge the importance of responsible AI, only a small minority (8%) have enforceable frameworks in place, falling to 2% in small firms.

“Our research indicates that many businesses are still laying the tracks while the AI train is in full motion,” said Charles Ross, Asia head of policy and insights at Economist Impact. “Without sustained investment in skills and strong governance, organisations risk undermining the long-term value AI can deliver.”

The findings reveal internal misalignment slowing progress. While 60% report strong leadership alignment on AI talent strategies, one in three executives cite resistance to change among employees and middle management as a key barrier to implementation.

Critical skills gaps also persist. While 96% of executives say cybersecurity is essential for AI deployment, only 20% believe their workforce is proficient. Significant shortfalls also exist in data privacy and bias detection.

As AI automates routine tasks, critical thinking and creativity are increasingly important—yet only around one-third of executives believe their workforce excels in these areas.

Keisuke Koyama, executive officer and senior general manager of the Corporate Marketing Division at Kyocera Document Solutions, said: “Skills, governance and leadership are key to unlocking AI ambition into sustainable value. Bridging these capability gaps is essential to responsible, people-centered digital transformation that delivers real business value.”

 

Airalo Simplifies Corporate Travel with Industry First “Self-Purchase” Feature

The new Airalo for Business feature reduces travel connectivity friction for both business travelers and enterprises.

SINGAPORE, March 23, 2026 /PRNewswire/ — Airalo, the world’s leading eSIM platform, today introduced an industry first, launching the ability for employees to use corporate or personal cards directly within the Airalo for Business solution, by simply switching to business mode. This new decentralized billing feature complements the platform’s other centralized billing option to ensure it meets the needs of all enterprises, regardless of their internal expense policies.

Thanks to the new product capabilities, business travelers can now purchase eSIMs for business trips directly within the Airalo app using a credit or debit card, which automatically syncs with the Airalo Partner Platform. This new decentralized feature ensures Airalo for Business integrates seamlessly within a company’s internal expense and billing policies. 

“Airalo for Business was engineered to make sure teams remain productive and connected without interruption; it is only logical that the payment and billing experiences should be as seamless as the connectivity itself,” said Stephanie Kazalac, Product Director for Partner Experience at Airalo. “This update reflects our commitment to building an ecosystem that empowers both enterprises and their employees with a flexible solution. The result is a product that offers organizations full visibility over costs, while simultaneously giving employees independence to connect instantly as soon as they arrive abroad.”

Empowering Employees, while Simplifying Administration

With the introduction of Business Mode, employees can now complete purchases using either corporate or personal cards directly within the Airalo app. Employees who have been registered to their company’s business account can toggle to ‘Pay with business account,’ during the eSIM purchase process, to directly sync the transaction with the Airalo Partner Platform.

This significantly improves the user experience for business travelers, who no longer need to wait for an admin to assign an eSIM.

For the enterprise, the model offers a “hands-off” approach to management without sacrificing financial discipline:

  • Automated Savings: Corporate rates and discounts are applied automatically to every employee purchase.
  • Real-Time Visibility: Admins gain full transparency into data usage and purchase history without the burden of managing individual payment plans.
  • No Overhead: The platform has no subscription fees, minimum monthly spend requirements, or hidden costs.
  • Billing Flexibility: Choose between employee-led reimbursement or centralized company billing to align seamlessly with internal expense policies.

“We understand that every enterprise manages costs differently, so it was vital that our product reflects that diversity of operations. With this new feature, we now offer flexible payment and billing options that allow businesses to scale global connectivity in alignment with their internal policies,” continued Stephanie Kazalac.

About Airalo for Business

Airalo for Business is the enterprise connectivity solution from Airalo, the world’s first and largest eSIM platform. Built for global teams, it enables companies to manage international connectivity through a centralized platform, with access to affordable, flexible eSIM plans across more than 200 countries and regions. With streamlined provisioning, real-time usage tracking, and simplified billing, Airalo for Business helps organizations stay connected worldwide while reducing roaming costs and operational complexity.

Security and Scale Trusted by over 55,000 employees worldwide, Airalo for Business is built on enterprise-grade security, featuring SOC 2 Type II compliance and SSO integrations. This ensures that as companies scale, their global connectivity remains secure, manageable, and cost-effective.

For more information on Airalo for Business and the new Self-Purchase features, visit www.partners.airalo.com

Contact: Elyce Behrsin, Principal PR Manager at Airalo, for inquiries, please email press@airalo.com

IBM Debuts New AI Enabled Digital Experiences for the 90th Masters Tournament

New generative AI and agentic capabilities help fans explore 50+ years of Masters history and gain deeper insight into every shot during the Tournament

ARMONK, N.Y., March 23, 2026 /PRNewswire/ — IBM (NYSE: IBM) and the Masters Tournament today announced new and enhanced digital fan features now available on the award-winning Masters digital platforms. The watsonx AI-powered capabilities – the latest in a 30-year collaboration between IBM and the Masters – are designed to bring the rich history and on-course excitement of the Tournament to life for millions of golf fans around the world.

(Photo credit: IBM)
(Photo credit: IBM)

Introducing Masters Vault Search with watsonx
The Masters Vault video archive has been transformed into an interactive experience, enabling fans worldwide to explore over 50 years of Masters Tournament final round broadcasts through simple, conversation-style prompts. A system of AI agents – powered by specialized solutions, including IBM’s Granite small language models (SLM) and agentic AI platform watsonx Orchestrate – built to instantly find precise clips within full-length replays, making it easy and fun to find your favorites or relive the Tournament’s greatest, most iconic moments.

Masters Vault Search is built with optical character recognition, speech-to-text transcription of broadcast commentary and scene detection to analyze footage. The Masters’ vast historical database is utilized to deliver metadata on each clip, including results dating back to 1968, as well as individual stroke data starting in 2015. 

Newly Enhanced ‘Hole Insights’
Returning for its third year, AI-powered Hole Insights will provide fans with more insights for greater accuracy around every shot taken by every player on every hole during the Masters. The newly enhanced feature combines on-course visuals with data-driven insights – such as historical scoring probabilities and contextual performance trends – helping fans better understand how each shot, position and decision impacts outcomes. Legendary caddie and commentator Jim ‘Bones’ Mackay advised the team behind the solution, lending his deep expertise and firsthand knowledge of one of golf’s most complex courses to help deliver more accurate, context-rich analysis.

The moment a ball comes to rest, its exact coordinates are captured and compared against historical data for the hole location. Watsonx then calculates the probabilities of making an eagle, birdie, par, bogey or more and generates an insight based on that analysis. (e.g. “Historically, from this spot, players across the field have a 12.5% chance of making birdie and an 81.25% chance of making par.”) Users will see a different insight for a golfer at the same position, depending on what shot they are taking.

“The Masters Tournament and IBM have continually raised the bar on unique digital experiences that blend cutting-edge technology with the timelessness of Augusta National Golf Club,” said Jonathan Adashek, Senior Vice President of Marketing and Communications at IBM. “The introduction of Masters Vault Search and updates to Hole Insights show how generative and agentic AI can transform vast amounts of data into meaningful insights – whether you’re a golf fan who wants to understand the implications of a single shot in real time, or a financial institution using AI to analyze millions of transactions to identify patterns and inform decisions.”

For 30 years, the Masters Tournament and IBM have pioneered the use of emerging technology to redefine fan experience. These new integrations join an already impressive suite of AI-enabled fan features on Masters digital platforms, including AI Highlights, Round in Three Minutes, My Group and the Masters app on Apple Vision Pro. IBM’s partnerships with the Masters and other iconic sports and entertainment organizations – Scuderia Ferrari HP, Wimbledon, the US Open, ESPN Fantasy Football, Grammys and UFC – are powered by the same AI hybrid cloud solutions used by IBM clients across industries to reach new levels of productivity, create better customer care experiences and make their business smarter.

The 90th Masters Tournament will be held from April 9 – 12 at Augusta National Golf Club in Augusta, Georgia. Check out all the IBM watsonx technologies in action by visiting Masters.com or the Masters app available on mobile devices, the Apple App Store and the Google Play Store.

About IBM
IBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Thousands of governments and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM’s long-standing commitment to trust, transparency, responsibility, inclusivity and service. Visit www.ibm.com for more information.

Media contact:
Paul Pettas, IBM
paulpettas@ibm.com

(Photo credit:IBM)
(Photo credit:IBM)

 

IBM Corporation logo.
IBM Corporation logo.

Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion

New capability combines executive assessment with AI-enabled simulations to reveal how leaders think and make decisions under pressure

LAS VEGAS, March 23, 2026 /PRNewswire/ — Heidrick & Struggles International, Inc., a premier provider of global leadership advisory and on-demand talent solutions, today announced Heidrick Immersive, a next generation, AI-enhanced leadership assessment platform.

Heidrick Immersive represents an innovative approach to leadership insight, positioning Heidrick & Struggles among the first leadership advisory firms to introduce a capability of this kind. While traditional assessments evaluate experience, track record, and self-reported behaviors, the new platform uses AI-enabled simulations of strategic inflection points, such as market shifts, technological disruption, and critical stakeholder decisions, to observe how leaders think, decide, and operate under pressure. Advanced behavioral analysis and real-time feedback translate those observations into actionable insights on decision making, adaptability, resilience, and team dynamics.

For the first time, leadership behavior can be observed in motion: consistently, rigorously, and in minutes rather than days. What emerges is a leader’s decision imprint—the observable pattern of how judgment holds under pressure and how assumptions evolve as conditions change.  Powered by AI and backed by behavioral science, the platform creates enterprise-level pressure with cinematic realism. Heidrick & Struggles translates this observable behavior into strategic, board-level insight, giving organizations a clearer view of how leaders will operate when the stakes are highest.

“Today’s leaders must navigate constant disruption, shifting stakeholder expectations, and accelerating technological change,” said David Peck, partner and global leader of the High-Impact Leadership Center of Excellence at Heidrick & Struggles. “By integrating AI-driven simulation and personalized feedback into our advisory offering, we’re advancing how organizations understand agility in leadership through science and human insights in tandem with AI. We’re excited to bring Heidrick Immersive to life and help organizations cultivate two essential CEO qualities: agility and resilience. As organizations navigate increasing complexity and disruption, the ability to adapt quickly and lead through uncertainty has never been more critical.”

The firm will showcase Heidrick Immersive at the Transform Conference, where attendees can experience live demonstrations of the platform and explore how immersive simulations can reveal leadership behaviors that traditional assessments may miss. Demonstrations will take place at Meeting Room Epernay 2.

To learn more about Heidrick Immersive, please visit https://www.heidrick.com/en/services/leadership/leadership-assessment.

About Heidrick & Struggles
Heidrick & Struggles is the world’s foremost advisor on executive leadership, driving superior client performance through premier human capital leadership advisory services. For more than 70 years, we have delivered value for our clients by leveraging unrivaled expertise to help organizations discover and enable outstanding leaders and teams. Learn more at www.heidrick.com.

Media Contact
Bianca Wilson
Global Director, Public Relations
Heidrick & Struggles 
bwilson@heidrick.com 

Youhug Media Hosts “Radiant Vision of Chinese Content” 2026 New Series Gala: Unveiling a Blockbuster Slate and Pioneering AI Drama Strategy

HONG KONG, March 23, 2026 /PRNewswire/ — Youhug Media recently concluded its prestigious “Radiant Vision: Youhug 2026 New Series Gala” in Hong Kong. During the event, the company unveiled an ambitious release slate featuring highly anticipated titles such as Blossoms of Power, Rebirth, The Awakening, Ctrl+Alt+Life, Confessions, The Road to Splendor, and Have it All. Beyond its diverse lineup of TV and film projects, Youhug Media officially announced a groundbreaking strategic roadmap for AI-generated drama series, demonstrating its vision and commitment to content innovation and industrial evolution. The gala saw the appearance of lead actors and creative teams who shared insights into their latest works, while official trailers and posters were released simultaneously online, garnering significant attention from industry professionals and audiences alike.


A Diverse Slate of Premium Productions Captivates the Industry

Themed “Radiant Vision,” the gala showcased a massive array of upcoming projects. Distinguished guests in attendance included Li Xiaojun, Director of the Sichuan Provincial Radio and Television Bureau; Zhang Hai, Deputy Director of the Sichuan Provincial Radio and Television Bureau; Xu Jingyi, Head of the TV Drama Division of the Shanghai Municipal Administration of Culture and Tourism; Chi Xiaoling, Second-level Investigator of the Radio, TV, and Online Audio-Visual Program Division of the Shanghai Municipal Administration; and Lu Jian, Chief Representative of the Hong Kong Trade Development Council in East China.

Lu Chao, President of Youhug Media, delivered an opening address outlining the company’s future strategy. He emphasized that “elevating quality is the ultimate weapon against change,” and pledged to “actively embrace AI empowerment to better tell Chinese stories”.

The project showcase kicked off with Blossoms of Power, starring Meng Ziyi and He Yu. The teaser’s tense score and powerful performances highlighted a world of undercurrents, where Eastern aesthetics meet a complex game of power, emotion, and destiny. This was followed by the hot-blooded period epic Rebirth, starring Li Yunrui, Huang Yang Tiantian, and Zhang Kangle. The series follows the journey of Zhuge Yue (Li Yunrui) and Chu Qiao (Huang Yang Tiantian) as they survive the Battle of the Icy Lake to bring peace to the world.

Ranging from Eastern aesthetic power struggles to hot-blooded ensemble epics, the latest slate from Youhug Media showcases a vast array of genres and distinct styles, designed to comprehensively meet the diverse preferences and high expectations of global audiences. Furthermore, Youhug Media remains steadfast in its commitment to a diversified strategic roadmap for film and television development.

Youhug’s 2026 lineup further expands into diverse genres:

  • The Awakening: A hardcore revenge action drama starring Zhang Kangle as a prisoner who endured trials in Heiyuan Prison from a young age. He escapes to Wangcheng to avenge his father, where he befriends Qi Jun (Zhou Jieqiong) and becomes entangled in the power struggles between the Yihesheng gang and the city’s rulers.
  • Ctrl+Alt+Life: This annual hot-blooded growth drama stars Zeng Shunxi, Zhang Kangle, Liu Xiening, and Jiang Lai. The story follows an accidental identity swap between two young men—one shedding his halo to rediscover his passion, while the other rises to the top of the competitive arena—offering a profound reflection on the choices and destinies of youth.
  • Confessions: This highly anticipated psychological thriller reunites the creative team behind The Pig, The Snake, and The Pigeon, starring Ethan Juan, Gingle Wang, and Yi-wen Chen. The narrative begins with a 2004 bombing and kidnapping case in Taipei that entwines three innocent families in a 20-year cycle of intergenerational conflict. Utilizing a highly stylized audiovisual language, the series explores the abyss of human nature and fissures in human nature through themes of high-stakes revenge and psychological fractures.
  • The Road to Splendor: Directed by Deng Ke and written by Nan Zhen, this period road movie stars Ding Yuxi and Deng Enxi. Moving beyond traditional domestic settings, the series uses a novel Eastern aesthetic to portray the survival and mutual redemption of salt merchant Zhao Ling and fallen noble daughter Fu Tingyun as they navigate a chaotic world.

Pioneering the AI Frontier and Future IP Ecosystem

Beyond the key upcoming projects for 2026, several projects currently in development were officially announced during the gala, showcasing a vast array of genres and unique creative highlights. Among them, the period legend Have it All (Yi Shou Zhai Xing Yi Shou Chui Di), which blends Eastern classical charm with contemporary significance, was heavily announced. Starring Meng Ziyi, the series follows the journey of Princess Regent Xiao Qitang as she navigates through conspiracies, eventually rewriting her destiny with wisdom and integrity in a high-energy plot filled with constant reversals.

Additionally, the new urban romance Ai,Love (Ai De Suan Fa) released an all-AI-produced concept teaser. Moving beyond a singular romantic narrative, the series explores the dilemmas of intimacy through the lens of three urban couples, serving as a “Contemporary Urban Emotional Survival Guide.” Also unveiled was Mo Yu Ji , a high-quality production blending time travel, romance, power struggles, and light comedy, which tells a story of choice, persistence, and redemption amidst chaotic times. Furthermore, the uniquely charming new work Hong Bai Xi Shi was officially announced, using a comedic shell to explore themes of life and death, encouraging audiences to regain the courage to love and be loved.

Following the enthusiastic response to the series MOBIUS (Bu Mian Ri), a newly upgraded film adaptation is also in preparation, aiming to innovate while maintaining the core charm of the original IP. The gala also featured The Annoyance of The Gods IP, based on the blockbuster work by Ma Boyong, which will reshape the legend of Journey to the West from a fresh perspective. Other new projects announced to further enrich Youhug Media’s content layout include Jin Li Yue Long Men, Da Jiang Ben Liu, Ran Yu, and Panda (Da Xiong Mao). Notably, the drama Under the Table (Tai Di), focusing on the stakes of human nature, also garnered significant attention for its potential to provide a brand-new viewing experience.

As a leading domestic film and television content creation company, Youhug Media has long been dedicated to premium drama creation and industrial production systems. During the gala, Youhug officially announced the establishment of its AICG Lab, marking its formal entry into the AI drama series track and its commitment to empowering more AI creators. The event featured the premiere of Qin Ling Qing Tong Gui Shi Lu, a fantasy suspense short drama created through a full-chain AI process. Based on the teaser, the project demonstrates high levels of completion and aesthetic value in its world-building, character performance, and atmospheric rendering, showcasing the refreshing advantages of AI tools.

Simultaneously, the two lead characters, Qin Lingyue and Lin Xiyan, were officially “signed” as Youhug’s first AI Actors. Youhug stated that while AI technology currently shortens production cycles and reveals new possibilities for deep integration with film and television creation, it remains in an exploratory stage. The company emphasized that real emotional resonance is paramount; the performances of human actors are irreplaceable and will become increasingly precious. Consequently, AI actors will only appear in AI-specific dramas and will not be used in live-action series.

By expanding from upcoming titles to AI-driven creations, Youhug Media has formed a full-category content ecosystem where long-form dramas, films, short plays, and AI series develop synergistically across genres such as period, reality, suspense, and action. The company remains committed to building an industry benchmark that balances artistic strength with market competitiveness, delivering works with depth, warmth, and value to contribute to the high-quality development of the industry.

“It Survived 40,000 Feet, Drier Than the Sahara”–The Ultimate K-Beauty Barrier Cream Just Landed on Amazon

The evolution of a 10-year R&D heritage that previously swept top US luxury department stores. Meet Dr.BRID C, the next-generation biotech skincare line launching on Amazon—all under $25.

NEW YORK and SEOUL, South Korea, March 23, 2026 /PRNewswire/ — Altitude 40,000 feet. Humidity below 20%. If you’ve ever looked in the mirror after a long-haul flight to find your skin rough, red, and completely parched, this new beauty brand’s origin story will instantly resonate with you.

Dr.BRID C, the next-generation biotech skincare line launching on Amazon
Dr.BRID C, the next-generation biotech skincare line launching on Amazon

Born out of the desperate need for VIPs and beauty professionals to protect their skin in harsh, Sahara-like cabin environments, the next-generation biotech K-beauty brand Dr.BRID C has officially launched on US Amazon.

The ‘Paradox of Beauty’: How We’re Destroying Our Own Skin
Even on the ground, our skin is under daily attack as if it were 40,000 feet in the air. Air conditioning, pollution, and ironically, our daily beauty routines—heavy makeup, harsh double-cleansing, and chemical exfoliation—are slowly stripping away our skin barrier.

To break this vicious cycle, Dr.BRID C goes beyond temporary fixes with a clear and uncompromising philosophy: “Defense Before Beauty.”

Luxury Skincare Science That Awakens ‘C-Peptide’
Dr.BRID C’s barrier-repairing prowess is rooted in a 10-year R&D heritage that previously dominated luxury US department stores like Barneys New York.

Rejecting conventional moisturizers that just suffocate the skin with heavy oils, their scientists developed a proprietary patented technology: PEPTIBRID®. This technology encapsulates a powerful collagen-signaling peptide in soothing zinc oxide, delivering it safely and deeply into the skin. In cell tests, this resulted in a massive 175.3% surge in ‘C-peptide,’ a key biomarker for new collagen synthesis.

“When trying to create a cream that could help skin survive a 14-hour flight, we realized surface hydration simply wasn’t enough,” says the Lead Researcher at Dr.BRID C. “Dr.BRID C helps build the fundamental strength skin needs to breathe and defend itself in any extreme environment.”

“Balanced and Springy”—Real Customers Prove the Barrier Miracle
Dr.BRID C focuses on rebuilding the skin’s core rather than just offering a temporary band-aid. And real customer reviews are already proving the miracle.

An Amazon reviewer who suffered from a compromised oil-water balance and tightness praised the texture and moisture retention: “This cream moisturizer is smooth and makes the skin feel soft after overnight wear without lingering filminess or discomfort. Skin does not feel greasy or oily but balanced and springy.”

Furthermore, testers who experienced extreme inner dryness from frequent travel and UV exposure testified to the overwhelming difference: “I have sensitive skin, so after traveling, UV exposure makes my skin reactive and dry… This feels like I’ve finally found the right cream. It spreads smoothly and absorbs quickly without leaving residue. It addresses inner dryness beautifully.”

The #40,000ft Cream Lineup: A Customized Barrier Trio (All Under $25)
Driven by the “Defense Before Beauty” philosophy, the launch centers around three targeted #40,000ft Creams designed for specific skin conditions.

  • #40,000ft Barrier Defense Basic Cream ($19.99): The absolute hero of the lineup. Formulated with an optimal 12ppm of PEPTIBRID®, this cream becomes your new daily shield if your oil-water balance has collapsed. It absorbs instantly without any greasiness, creating the perfect velvet canvas for your makeup to grip onto.
  • #40,000ft Hydro Relief Cream ($21.99): A cooling gel-cream packed with a high concentration of 21ppm PEPTIBRID® for sensitized, dehydrated skin. Just one use blocks Trans-Epidermal Water Loss (TEWL) by 30.81%, delivering an instant hit of deep hydration.
  • #40,000ft Intensive Moisture Basic Cream ($21.99): The ultimate age-defying density care. Boasting 22ppm of PEPTIBRID®—the highest concentration in the lineup—it goes beyond barrier support to visibly improve signs of aging like enlarged pores, rough texture, and eye wrinkles over 8 weeks.

Rounding out the collection is a synergistic, clean-formula lineup—including a pH-balancing toner and a 100-hour moisture-locking serum—all priced under $25. If you’re ready to experience cutting-edge barrier defense that survives even the harshest conditions, Dr.BRID C is available now on Amazon(https://www.amazon.com/drbridc?maas=maas_adg_EE29DA495FDC3C85E3F4533006833714_afap_abs&ref_=aa_maas&tag=maas).

 

WuXi XDC Delivers Exceptional Performance in 2025, Reinforcing Global Leadership in Bioconjugate CRDMO

  • Revenue increased by 46.7% YoY to RMB 5,944 million
  • Gross profit surged by 72.5% YoY to RMB 2,139 million, with its margin of 36.0%, a 5.4 percentage points increase compared to 2024
  • Adjusted net profit increased by 69.9% YoY to RMB 1,559 million, with its margin of 26.2%, a 3.6 percentage points increase compared to 2024(excluding net interest income and exchange impact)
  • The total global customer base expanded to over 640 companies, and 14 out of the TOP 20 global pharmaceutical companies have partnered with us
  • The total number of iCMC projects reached to 252, with 70 newly signed iCMC projects
  • The robust PPQ pipeline: Secured 18 PPQ projects with 10 new PPQ projects added in 2025
  • The total backlog grew to US$1.49 billion, representing a strong 50.3% YoY growth
  • Winner of “Best CDMO” and “Best CRO” Awards: Three consecutive “Best CDMO” Awards from 2023 to 2025 at World ADC Awards, and “Best CRO” Awards at 2025 World ADC Awards

SHANGHAI, March 23, 2026 /PRNewswire/ — WuXi XDC Cayman Inc. (the “WuXi XDC” or the “Group”, stock code: 2268.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) focused on the bioconjugate market, is pleased to announce its annual results for 2025 (the “Reporting Period”).

Management Discussion on 2025 Annual Results and Recent Events (Jan to March 2026)

  • Rapid Growth – As a leading player in the thriving, innovative global bioconjugates industry, the Group has maintained its rapid business growth by providing world-class bioconjugates CRDMO integrated services and empowering its global partners to accelerate and transform ADC and broader bioconjugate development.
  • Strategic M&A – Beyond strong operational results, we advanced two strategic M&A initiatives that elevated our extensive capabilities and expanded our global footprint, enabling us to better serve the global customers. (including the Suzhou site from the acquisition of BioDlink, and the Hefei site acquisition)
  • Technology Engine – Breakthrough advancements across our WuXiDARx™, X-LinC, and WuXiTecan-1 & WuXiTecan-2 platforms are accelerating the development of next-generation bioconjugates, positioning us at the forefront of innovation and drive value creation.
  • Recent Events – To further advance our evolving growth strategy and strengthen our next phase of expansion, we continue to scale and innovate across our payload-linkers platform.
    • Jiangyin site: we have planned a new manufacturing facility as our Jiangyin site. This strategic investment establishes scalable production capabilities for emerging novel payload-linkers, including dual-payloads, AOC, and as well as the PPQ batches supply for late-stage projects. 5x the volume of payload-linker production compared to current level at Wuxi site
    • Technology platform-driven value creation: We have invested consistently in R&D innovation to unlock potential value. In February, we entered into a new flagship strategic collaboration with Earendil Labs, to out-licensing our proprietary WuXiTecan-2, with total potential consideration of up to US$885 million, including upfront, milestone and royalty payments.

Financial Highlights for Annual Results of 2025

Revenue

The Group’s revenue increased by 46.7% YoY to RMB 5,944 million for the year ended December 31, 2025. This increase was primarily attributable to (i) the growth in the number of customers and projects, driven by continued active development of the global ADC and broader bioconjugates market, (ii) the increasing market share through the Group’s established position as a leading ADC CRDMO service provider in that market, and (iii) the steady advancement of the Group’s projects into later stages.

Gross Profit and Its Margin

The Group’s gross profit increased by 72.5% YoY to RMB 2,139 million, with a gross profit margin of  36.0% for the year ended December 31, 2025, and a 5.4 percentage points increase compared to that of 2024. This improvement is driven by (i) the enhanced overall operation and manufacturing efficiency, (ii) the utilization ratio of production facilities continued to improve, mainly due to strong customer demand, and (iii) the successful ramp-up of operating production lines including BCM2 L2 and DP3.

Adjusted Net Profit and Its Margin

The Group’s adjusted net profit increased by 69.9% YoY to RMB 1,559 million, demonstrating the strong profit growth momentum of the Group’s core operating business. The margin of adjusted net profit was 26.2% for the year ended December 31, 2025, and a 3.6 percentage points increase compared to that of 2024.

Customers and Projects Highlights for Annual Results of 2025

  • We have continuously expanded our customer base, reaching a cumulative total of 643, through strong customer-enabling empowerment.
  • The “Enable, Follow, and Win the Molecule” strategy continued to drive sustained and rapid project growth. The total number of integrated projects (“iCMC projects”) is 252, with a record 70 newly signed integrated projects.
  • The Group has successfully secured over 18 PPQ projects, with 10 new PPQ projects added in 2025.
  • The Group has a diversified project base covering both innovative ADC and broader bioconjugate (“XDC”) projects. The total number of integrated ADC projects reached 226, and the number of integrated XDC projects increased to 26.
  • In 2025, the Group explored over 5,600 molecules of multiple modalities, including bispecific ADCs, dual-payload ADCs, degrader-antibody conjugates (DAC), antibody-oligonucleotide conjugates (AOC), antibody-peptide conjugates (APC), lysosome-targeting chimaeras (LYTAC), etc.

Fully Integrated R&D Technology Platform for Annual Results of 2025

The Group strives to empower customers with cutting-edge conjugation and payload-linker technologies, along with extensive expertise in bioconjugate development capabilities to fulfill diverse R&D requirements.

WuXiDARx™

  • The proprietary WuXiDARx™ technology aims to meet customers’ demands for highly homogeneous ADCs with a wide range of DAR values at clinically validated conjugation sites.
  • WuXiDARx™ technology enables dual-payload ADC generation via native interchain cysteine sites without antibody engineering or enzymatic conjugation, offering a streamlined, cost-effective single-platform solution.
  • The platform has successfully facilitated customers to bring 8 ADC pipelines from preclinical stage to clinical stage.
  • WuXiDAR2™ offers narrow DAR distribution with a simple process; WuXiDAR1™ combines the process of WuXiDAR2™ with thiol-rebridging connector to produce homogeneous DAR1 which could be potentially developed in AOCs/APCs.

X-LinC

  • The proprietary X-LinC technology could potentially enhancing ADC stability and therapeutic window since the data demonstrated that it significantly improves plasma stability by replacing the maleimide connector.

WuXiTecan

  • The Group is developing its proprietary payload and hydrophilic linker to enable ADCs with better stability, hydrophilicity, and tolerability.
  • The newly launched WuXiTecan-1 and WuXiTecan-2 platforms have demonstrated excellent efficacy and safety profiles in preclinical studies. Notably, WuXiTecan-2 based dual-payload (MMAE+WuXiTecan-2) ADC achieved enhanced anti-tumor efficacy in CDX model.
  • Customers are actively evaluating the performance of WuXiTecan‑1 and WuXiTecan‑2, with potential collaborations under discussion involving our proprietary payloads featuring novel mechanisms of action and multi‑payload platform.

Capacity Expansion & Business Operation Updates for Annual Results of 2025

  • The total number of full-time employees increased to 2,662 in the Group, driven by rapid business growth and the Group’s capacity expansion.
  • All the Group’s manufacturing operations are conducted in accordance with the GMP regulations set by the FDA, EMA, and NMPA. The Group has completed over 200 GMP audits from global customers, including 20 audits by EU Qualified Persons.
    • Wuxi site: Further increased its integrated manufacturing capacities. The DP5 and DP6 facility in Wuxi is currently under construction.
    • Singapore site: On track to begin GMP release in 2026 1H, driven by solid overseas customer demand. This state-of-the-art site expands our global manufacturing footprint and reinforces our “China + Singapore” dual sourcing strategy, delivering enhanced supply security and operational agility for customers worldwide.
    • Shanghai site: Further investments in the discovery and technology frontier as global R&D center.
  • Executed two strategic acquisitions aligned with core growth objectives, significantly strengthening manufacturing and R&D capabilities:
    • Suzhou site: the acquisition of BioDlink further enhances our integrated bioconjugate production covering mAb, DS and DP, and expands our customer base and project pipelines.
    • Hefei site: the acquisition expands our expertise in peptide and oligonucleotide synthesis, enabling accelerated development of novel conjugates.
  • The Group was named the winner of “Best CDMO” for the third consecutive year in 2023, 2024 and 2025, as well as “Best CRO” at the 2025 World ADC Awards.
  • The Group also received multiple awards from the 2025 Extel ranking in diverse categories, signifying our commitment to high-quality corporate governance and investor interactions.
  • The Group is committed to strengthen ESG governance and received top-tier ratings in ESG rankings, reflecting our exceptional performance in corporate responsibility, risk management, and ethical business conduct.

CEO Comment

Dr. Jimmy Li, CEO of WuXi XDC, stated, “2025 was a transformative year for WuXi XDC, as we solidified our leadership in global biconjugate CRDMO market and completed several key strategic initiatives: we expanded our production capacity footprint through ‘organic expansion + strategic acquisition’ and established our Singapore site, which is expected to achieve GMP release in the first half of 2026, building a truly global supply chain system. Recently, we also entered into a technology licensing partnership for WuXiTecan-2, helping our clients accelerate bioconjugates development and realize the value resonance of our proprietary technology platforms. Looking ahead to 2026, we will continue to uphold our unwavering commitment to innovation, operational excellence, and collaboration with our clients. We will empower our customers with continuous evolution, bring breakthrough therapies to more patients worldwide, and lead the development of the industry.”

Key Financials Ratios (For the Year Ended December 31)

Key Financials (RMB Mn)

2025

2024

YoY%

Revenue

[5,944]

4,052

[46.7%]

Gross Profit 

[2,139]

1,240

[72.5%]

Margin (%)

[36.9%]

30.6 %

Adjusted Net Profit 

[1,559]

917

[69.9%]

Margin (%)

[26.2%]

22.6 %

About WuXi XDC

WuXi XDC Cayman Inc. (“WuXi XDC”, stock code: 2268.HK) is a leading global CRDMO focused on bioconjugate market. It provides end-to-end contract research, development and manufacturing services for ADC and broader bioconjugates. For more information about WuXi XDC, please visit: www.wuxixdc.com 

Contacts

Investor: wuxixdc.ir@wuxibiologics.com
Media: wuxixdc_pr@wuxibiologics.com
BD: wuxixdc_info@wuxibiologics.com

Forward-Looking Statements

This presentation may contain certain “forward-looking statements” which are not historical facts, but instead are predictions about future events based on our beliefs as well as assumptions made by and information currently available to our management. Although we believe that our predictions are reasonable, future events are inherently uncertain, and our forward-looking statements may turn out to be incorrect. Our forward-looking statements are subject to risks relating to, among other things, the ability of our service offerings to compete effectively, our ability to meet timelines for the expansion of our service offerings, and our ability to protect our customers’ intellectual property. Our forward-looking statements in this presentation speak only as of the date on which they are made, and we assume no obligation to update any forward-looking statements except as required by applicable law or listing rules. Accordingly, you are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. All forward-looking statements contained herein are qualified by reference to the cautionary statements set forth in this section.

Use of Adjusted Financial Measures (Non-IFRS Measures)

The Group defines “adjusted net profit attributable to owners of the Company” as net profit attributable to owners of the Company after elimination of share-based compensation expense as non-cash expenditure, net foreign exchange loss or gain as non-operating item, non-recurring/one-off transaction costs as non-operating item, and net of interest income and finance costs as non-operating item. We believe that the adjusted financial measures used in this presentation are useful for understanding and assessing underlying business performance and operating trends, and we believe that management and investors may benefit from referring to these adjusted financial measures in assessing our financial performance by eliminating the impact of certain unusual and non-recurring items that we do not consider indicative of the performance of our business. However, the presentation of these non-IFRS financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with IFRS. You should not view adjusted results on a stand-alone basis or as a substitute for results under IFRS, or as being comparable to results reported or forecasted by other companies.

 

Hotel Linen Manufacturer HANBI Optimizes Hotel ROI with 30% More Durable, High-Hygiene Bedding

By integrating factory-direct manufacturing and skin-friendly safety standards, HANBI delivers high-durability hotel bedding solutions that stabilize procurement budgets for 2,000+ luxury hospitality brands globally.

NANNING, CHINA, March 23, 2026 /PRNewswire/ — For decades, the global hospitality conversation has been dominated by mattress “hardware” from giants like Sealy and Simmons. But a critical shift is happening in the “software” of sleep: the hotel linens that define a guest’s direct tactile experience. HANBI, a vertically integrated hotel linen manufacturer, today announced the global expansion of its high-performance hotel bedding solutions. By addressing the industry’s chronic struggle with textile longevity, HANBI’s new line promises to extend product lifespan by 30%, offering a strategic edge to hotel owners worldwide.

HANBI delivers factory-direct bedding solutions that combine high-performance durability with the soft, tactile elegance demanded by the world's leading hospitality groups.
HANBI delivers factory-direct bedding solutions that combine high-performance durability with the soft, tactile elegance demanded by the world’s leading hospitality groups.

In an era of rising inflation, HANBI is redefining hotel ROI. The company controls the entire supply chain from raw yarn to the final product. By merging large-scale R&D with a “Factory-to-Hotel” direct model, it helps global hospitality partners—including Howard Johnson and Accord Hotels—reduce procurement overhead by 5% to 10%.

Engineered for Longevity: The 30% Advantage
The primary drain on a hotel’s linen budget is the rapid deterioration caused by industrial laundering. HANBI has neutralized this via its proprietary reinforced weaving technology. This ensures that every hotel bedding set maintains its structure, whiteness, and “first-day” feel for up to 30% longer than standard industry alternatives.

“We don’t just weave fabric; we engineer performance for the modern hotel linen factory,” says a spokesperson for HANBI. “Our linens undergo rigorous pre-shrinking and high-temperature setting. This ensures that a HANBI bed sheet retains its crisp, white, ‘first-day’ aesthetic, which is essential for any hotel luxury bedding standard. For a hotel owner, that 30% extra life is pure profit.”

Professional Hygiene Standards in a Luxury Setting
Post-pandemic travelers demand more than just comfort; they demand uncompromising hygiene. HANBI’s unique advantage lies in its dual-track production: applying the same strict hygiene standards found in their hospital bed sheets to their commercial hotel towels and linens. All core products are manufactured under strict safety standards, guaranteeing they are skin-friendly and free from harmful irritants. This remains a critical benchmark for eco-conscious wholesale hotel supplies.

One-Stop Integration: From Hotel Pillows to Amenities
HANBI’s “One-Stop” philosophy simplifies the fragmented procurement process. Their integrated catalog covers every guest touchpoint:

  • Hotel Bedding & Sets: High-thread-count cotton with superior breathability and durability.
  • Hotel Towels & Bathrobes: High-GSM, long-staple cotton for maximum absorbency and softness.
  • Guest Room Accessories: From hotel pillows to ergonomic slippers and bespoke amenity kits that align with a brand’s unique DNA.

Market Validation & Global Reach
Late shipments are a constant headache for hotel managers. HANBI avoids this drama by maintaining a 98% on-time delivery rate. This consistency explains why 90% of their clients have stuck with the company for three years or more. Beyond just shipping products, HANBI acts as an agile OEM and ODM partner. This gives boutique owners and global giants the power to prototype a signature look and scale it across properties without the usual lead-time headaches or budget creep.

About HANBI
HANBI is a leading vertically integrated hotel linen manufacturer specializing in professional hospitality textiles. Unlike traditional trading companies, HANBI operates its own state-of-the-art hotel linen factory, ensuring total control over quality, cost, and lead times. From premium hotel linens to sustainable fabrics meeting the rigorous hygiene standards, HANBI is the “invisible champion” supporting the world’s most demanding hospitality brands.

For more information, please visit: https://www.hanbi-hotelsupplies.com/

Media Contact:
Company Name: Guangxi Hanbi Textile Co., Ltd.
Telephone: 0771-5585836
Email: sammi@hanbitextile.com
WhatsApp: +86 15878178593